Artemis Therapeutics, Inc.

Jun 19, 2018

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

Jun 12, 2018

Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

Jun 07, 2018

New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

Apr 16, 2018

Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

Nov 28, 2017

Artemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections

Nov 06, 2017

Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria

Oct 26, 2017

Artemis Therapeutics Appoints Brian M. Culley As Chief Executive Officer